Lombard Odier Asset Management (Switzerland) SA - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Switzerland) SA ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,908,366
-42.9%
607,760
-10.9%
0.15%
-46.1%
Q3 2022$3,343,000
+3.7%
682,300
-12.4%
0.28%
+4.0%
Q2 2022$3,224,000
-35.5%
778,769
-9.5%
0.27%
-30.4%
Q1 2022$5,001,000
-56.7%
860,702
-44.1%
0.39%
-46.8%
Q4 2021$11,550,000
-9.1%
1,539,994
+9.2%
0.74%
-6.6%
Q3 2021$12,702,000
-12.1%
1,409,736
+16.8%
0.79%
+7.6%
Q2 2021$14,447,000
+35.9%
1,206,941
+42.3%
0.73%
+4.0%
Q1 2021$10,631,000848,4290.70%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders